The National Institute on Aging-Alzheimer’s Association Framework on AD provides biomarker profiles of individuals in the AD spectrum using three types of biomarkers—Aβ (A), tau (T), and neurodegeneration (N), known as the ATN framework. The gene discussed is MAPT; the disease is Alzheimer disease.